GEN2 NEUROSCIENCE
Gen2 Neuroscience develops therapeutics for the treatment of dementia targeting abnormal forms of the essential cellular protein tau.
GEN2 NEUROSCIENCE
Industry:
Biotechnology Life Science Therapeutics
Founded:
2016-01-01
Address:
Manchester, Manchester, United Kingdom
Country:
United Kingdom
Total Employee:
1+
Status:
Active
Total Funding:
0
Similar Organizations
Alligator Bioscience
Alligator Bioscience develops antibody-based immunotherapies for the treatment of cancer by using its protein optimization technology FIND®.
ATAI Life Sciences
ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.
Galera Therapeutics
Galera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.
Current Advisors List
Founder
Investors List
Dementia Discovery Fund
Dementia Discovery Fund investment in Seed Round - Gen2 Neuroscience
More informations about "Gen2 Neuroscience"
Gen2 – drug discovery company
Gen2 Neuroscience Ltd ©2023. ↑See details»
Gen2 Neuroscience - Crunchbase Company Profile
Where is Gen2 Neuroscience 's headquarters? Gen2 Neuroscience is located in Manchester, Manchester, United Kingdom. Who invested in Gen2 …See details»
Our Science – Gen2 - Gen2 Neuro
Gen2 Neuroscience Ltd ©2023. ↑See details»
Our Team – Gen2
Scientific Founder and Chief Executive Officer Rick Livesey MD PhD. Chief Operating Officer Emily Scraggs PhD. Chairman Mark Treherne PhDSee details»
Gen2 Neuroscience - Funding, Financials, Valuation & Investors
Gen2 Neuroscience develops therapeutics for the treatment of dementia targeting abnormal forms of the essential cellular protein tau. New. Resources. ... How much funding has this …See details»
Gen2 2025 Company Profile: Valuation, Funding & Investors
Gen2 General Information Description. Developer of therapeutics intended to slow the progression of dementia. The company's platform utilizes advanced stem cell technology to …See details»
GEN2 NEUROSCIENCE LTD Company Profile - Dun & Bradstreet
Gen2 neuroscience ltd. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / united kingdom / …See details»
DDF invests in Gen2 Neuroscience Ltd - SV Health Investors
Jun 3, 2016 About Gen2 Neuroscience Ltd Gen2 is a seed-stage company founded in January 2016 based in Cambridge UK using neuronal platforms (human diseased and healthy neurons …See details»
GEN2 NEUROSCIENCE LTD overview - Companies House
Filing history for GEN2 NEUROSCIENCE LTD (09939477) People for GEN2 NEUROSCIENCE LTD (09939477) More for GEN2 NEUROSCIENCE LTD (09939477) Registered office address …See details»
Gen2 Neuroscience | Company | RadialReport
Gen2 Neuroscience is a dementia drug discovery company. They develop therapeutics for the treatment of dementia targeting abnormal forms of the essential cellular protein tau. Their work …See details»
Gen2 Neuroscience Ltd. - Drug pipelines, Patents, Clinical trials
Explore Gen2 Neuroscience Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
GEN2 NEUROSCIENCE - VentureRadar
GEN2 NEUROSCIENCE VentureRadar profile. Find out more about GEN2 NEUROSCIENCE including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Gen2 Neuroscience - Crunchbase
Gen2 Neuroscience develops therapeutics for the treatment of dementia targeting abnormal forms of the essential cellular protein tau.See details»
Gen2 Neuroscience Ltd.:Company Profile & Technical …
Sep 28, 2023 Gen2 Neuroscience Ltd. is headquartered in United Kingdom Manchester. Gen2 Neuroscience Ltd. was founded in 2016. Gen2 Neuroscience Ltd. has a total of 15 patents . …See details»
GEN2 NEUROSCIENCE LTD - Companies House
GEN2 NEUROSCIENCE LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»
Gen2 Neuroscience - Updates, News, Events, Signals & Triggers
Gen2 Neuroscience develops therapeutics for the treatment of dementia targeting abnormal forms of the essential cellular protein tau. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
News – Gen2 - Gen2 Neuro
Gen2 Neuroscience Ltd ©2023. ↑See details»
Patents Assigned to Gen2 Neuroscience Limited
Jun 29, 2020 Applicant: Gen2 Neuroscience Limited Inventors: Frederick John Livesey, Clare Jones TAU EPITOPE AND BINDING MOLECULES. Publication number: 20220265819 …See details»
Hmgb2 improves astrocyte to neuron conversion by increasing the ...
Apr 17, 2025 Background Direct conversion of reactive glial cells to neurons is a promising avenue for neuronal replacement therapies after brain injury or neurodegeneration. The …See details»
A dyad of human-specific NBPF14 and NOTCH2NLB ... - Science
Mar 26, 2025 DEVELOPMENTAL NEUROSCIENCE. Share on. A dyad of human-specific NBPF14 and NOTCH2NLB orchestrates cortical progenitor abundance crucial for human …See details»